THE INFLUENCE OF EPICARDIAL ADIPOSE TISSUE THICKNESS ON THE RISK OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ARTERIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Starodubtseva, Irina [1 ]
Statsenko, Michail [2 ]
Derevyanchenko, Marya [2 ]
Streltsova, Anastasya [2 ]
Pashkova, A. A. [1 ]
机构：
[1] NN Burdenko Voronezh State Med Univ, Internal Dis, Voronezh, Russia
[2] Volgograd State Med Univ, Internal Dis, Volgograd, Russia
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SaaG052
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Non-Alcoholic Fatty Pancreas Disease is Associated with Increased Epicardial Adipose Tissue and Aortic Intima-Media Thickness
    Kul, Selim
    Karadeniz, Aysegul
    Dursun, Ihsan
    Sahin, Sinan
    Cirakoglu, Omer Faruk
    Sayin, Muhammet Rasit
    Turan, Turhan
    Ates, Ahmet Hakan
    ACTA CARDIOLOGICA SINICA, 2019, 35 (02) : 118 - 125
  • [32] Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications
    Byrne, Christopher D.
    Targher, Giovanni
    DIABETES OBESITY & METABOLISM, 2022, 24 : 28 - 43
  • [33] Non-alcoholic fatty liver disease and adipose tissue-related hormones: A possible link with cardiovascular disease
    Baou, Katerina
    Vlachopoulos, Charalambos
    Manesis, Emmanuel
    Ioakeimidis, Nikolaos
    Dima, Ioanna
    Xaplanteris, Panagiotis
    Papatheodoridis, Georgios
    Archimandritis, Athanasios
    Stefanadis, Christocloulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A333 - A333
  • [34] MicroRNAs in the Liver and Visceral Adipose Tissue in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Soronen, Jarkko
    Perttila, Julia
    Yki-Jarvinen, Hannele
    Olk-Konen, Vesa
    DIABETES, 2012, 61 : A43 - A44
  • [35] Non-alcoholic fatty liver disease and cardiovascular disease
    Santos, Raul D.
    Agewall, Stefan
    ATHEROSCLEROSIS, 2012, 224 (02) : 324 - 325
  • [36] Liver Fibrosis: An Independent Risk Factor for Cardiovascular Disease in Patients with Non-alcoholic Fatty Liver Disease
    McNally, Bridgette B.
    Fallon, Michael
    Rangan, Pooja
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S548 - S549
  • [37] Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension
    Rozhdestvenska, Anastasiia
    Zhelezniakova, Natalia
    AMERICAN HEART JOURNAL, 2022, 254 : 242 - 243
  • [38] DYSLIPIDEMIA AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH NON-ALCOHOLIC FATTY PANCREATIC DISEASE
    Gromova, M. A.
    Kosyura, S. D.
    Kislyak, O. A.
    Starodubova, A. V.
    ATHEROSCLEROSIS, 2020, 315 : E169 - E170
  • [39] Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndrome
    Gathercole, Laura L.
    Hazlehurst, Jonathan M.
    Armstrong, Matthew J.
    Crowley, Rachel
    Boocock, Sarah
    O'Reilly, Michael W.
    Round, Maria
    Brown, Rachel
    Bolton, Shaun
    Cramb, Robert
    Newsome, Phillip N.
    Semple, Robert K.
    Paisey, Richard
    Tomlinson, Jeremy W.
    Geberhiwot, Tarekegn
    LIVER INTERNATIONAL, 2016, 36 (11) : 1704 - 1712
  • [40] Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease
    Estep, M.
    Armistead, D.
    Hossain, N.
    Elarainy, H.
    Goodman, Z.
    Baranova, A.
    Chandhoke, V.
    Younossi, Z. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 487 - 497
12345